Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. F. Thall
Platelet-Derived Growth Factor Receptor Inhibition and Chemotherapy for Castration-Resistant Prostate Cancer With Bone Metastases
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Treatment of Castration-Resistant Prostate Cancer and Bone Metastases With Radium-223 Dichloride
International Journal of Urological Nursing
Urology
Nursing
Nephrology
The Α-Receptor for Platelet-Derived Growth Factor as a Target for Antibody-Mediated Inhibition of Skeletal Metastases From Prostate Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Radium-223 for the Treatment of Patients With Castration-Resistant Prostate Cancer With Bone Metastases
Medical Council
Radium-223 for the Management of Bone Metastases in Castration-Resistant Prostate Cancer
Journal of the Advanced Practitioner in Oncology
The -Receptor for Platelet-Derived Growth Factor Confers Bone-Metastatic Potential to Prostate Cancer Cells by Ligand- And Dimerization-Independent Mechanisms
Cancer Research
Cancer Research
Oncology
Platelet Derived Growth Factor a (PDGFA; PDGF1); Platelet Derived Growth Factor Receptor (PDGFR)
Science-Business eXchange
Androgen Receptor Inhibitor–induced “BRCAness” and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
Effect of Platelet-Derived Growth Factor Receptor-Β Inhibition With STI571 on Radioimmunotherapy
Cancer Research
Cancer Research
Oncology
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
PLoS ONE
Multidisciplinary
